Figure 5From: Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effectsIn vivo tumor treatment experiments. Groups of C57BL/6 mice (5 per group) were subcutaneously challenged with 5 × 104/mouse of TC-1 tumor cells. Tumor challenged mice were treated with apigenin and/or E7-HSP70 DNA vaccine as indicated in Figure 3. Untreated TC-1 tumor-bearing mice were used as a control. (A) Line graph depicting the tumor volume in TC-1 tumor bearing mice treated with apigenin and/or E7-HSP70 DNA. (B) Kaplan & Meier survival analysis of TC-1 tumor challenged mice treated with apigenin and/or E7-HSP70 DNA. Data shown are representative of two experiments performed (mean ± SD).Back to article page